| Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph … MJ Wieduwilt, W Stock, A Advani, S Luger, RA Larson, M Tallman, ... Leukemia 35 (7), 2076-2085, 2021 | 43 | 2021 |
| Distribution and trends of hematology and oncology research in Latin America: a decade of uncertainty AM Acevedo, A Gómez, HA Becerra, AP Ríos, PC Zambrano, EP Obando, ... Cancer 120 (8), 1237-1245, 2014 | 33 | 2014 |
| Colonization with fluoroquinolone-resistant Enterobacterales decreases the effectiveness of fluoroquinolone prophylaxis in hematopoietic cell transplant recipients MJ Satlin, L Chen, C Douglass, M Hovan, E Davidson, R Soave, ... Clinical Infectious Diseases 73 (7), 1257-1265, 2021 | 30 | 2021 |
| Critical Thinking in Clinical Research: Applied Theory and Practice Using Case Studies F Fregni, BMW Illigens Oxford University Press, 2018 | 29 | 2018 |
| Combined use of tofacitinib (pan-JAK inhibitor) and ruxolitinib (a JAK1/2 inhibitor) for refractory T-cell prolymphocytic leukemia (T-PLL) with a JAK3 mutation A Gomez-Arteaga, E Margolskee, MT Wei, K van Besien, G Inghirami, ... Leukemia & lymphoma, 2019 | 27 | 2019 |
| High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma A Gomez-Arteaga, TM Mark, D Guarneri, PJ Christos, U Gergis, ... Bone marrow transplantation 54 (12), 2027-2038, 2019 | 23 | 2019 |
| Clinical outcomes in breast cancer patients with HIV/AIDS: a retrospective study A Gomez, AJ Montero, J Hurley Breast cancer research and treatment 149, 781-788, 2015 | 21 | 2015 |
| Minimal Residual Disease in Acute Myeloid Leukemia A Gomez-Arteaga, ML Guzman Biological Mechanisms of Minimal Residual Disease and Systemic Cancer, 111-125, 2018 | 14 | 2018 |
| Comparison of multiple clinical testing modalities for assessment of NPM1-mutant AML A Lopez, S Patel, JT Geyer, J Racchumi, A Chadburn, P Simonson, ... Frontiers in Oncology 11, 701318, 2021 | 13 | 2021 |
| Predictors of Covid-19 Vaccination Response After In-Vivo T-Cell–Depleted Stem Cell Transplantation O Chaekal, A Gomez-Arteaga, Z Chen, R Soave, T Shore, S Mayer, ... Transplantation and Cellular Therapy 28 (9), 618. e1-618. e10, 2022 | 11 | 2022 |
| Recent advances in allogeneic hematopoietic cell transplantation for acute myeloid leukemia A Gomez-Arteaga, B Gyurkocza Current Opinion in Hematology 27 (2), 115-121, 2020 | 11 | 2020 |
| Handbook of hematologic malignancies DA Sallman, A Chaudhury, J Nguyen, L Zhang Springer Publishing Company, 2020 | 10 | 2020 |
| Presentation, treatment, and outcomes of Haitian women with breast cancer in Miami and Haiti: disparities in breast cancer—a retrospective cohort study A Gomez, V DeGennaro, SHL George, IM Reis, E Santamaria, GF Westin, ... Journal of global oncology 3 (4), 389-399, 2017 | 10 | 2017 |
| Anti Myelin-Associated-Glycoprotein Antibody Peripheral Neuropathy Response to Combination Chemoimmunotherapy With Bendamustine/Rituximab in a Patient With Biclonal IgM κ and … A Gomez, JE Hoffman Clin Lymphoma Myeloma Leuk. 16 (7), e101-8., 2016 | 9 | 2016 |
| Routine interim disease assessment in patients undergoing induction chemotherapy for acute myeloid leukemia: Can we do better? G Campuzano‐Zuluaga, Y Deutsch, M Salzberg, A Gomez, F Vargas, ... American journal of hematology 91 (3), 277-282, 2016 | 9 | 2016 |
| Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML K Menghrajani, A Gomez-Arteaga, R Madero-Marroquin, MJ Zhang, ... Blood advances 6 (3), 828-847, 2022 | 7 | 2022 |
| Pre-Hematopoietic Stem Cell Transplantation Rituximab for Epstein-Barr Virus and Post-Lymphoproliferative Disorder Prophylaxis in Alemtuzumab Recipients C Patel, M Pasciolla, R Abramova, D Salerno, A Gomez-Arteaga, ... Transplantation and Cellular Therapy 29 (2), 132. e1-132. e5, 2023 | 6 | 2023 |
| Updated survival analysis of two sequential prospective trials of R‐MACLO‐IVAM followed by maintenance for newly diagnosed mantle cell lymphoma PJ Hosein, JD Sandoval‐Sus, D Goodman, AG Arteaga, I Reis, J Hoffman, ... American journal of hematology 90 (6), E111-E116, 2015 | 6 | 2015 |
| Clinical utility of morphological evaluation of day 14 bone marrow biopsies in acute myeloid leukemia patients undergoing standard induction chemotherapy: time to change practice? YE Deutsch, G Campuzano-Zuluaga, MP Salzberg, AG Arteaga, JM Watts, ... Blood 124 (21), 1004, 2014 | 5 | 2014 |
| Cord blood transplants supported by unrelated donor CD34+ progenitor cells A Gomez-Arteaga, N Orfali, D Guarneri, MM Cushing, U Gergis, J Hsu, ... Bone Marrow Transplantation 55 (12), 2298-2307, 2020 | 4 | 2020 |
